HALL HEWETT: Open Payments
NPI 1033501481 · SAGINAW, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$468 in 23 payments from 12 companies in 2025. Trend: 2023 $275 · 2024 $187 · 2025 $468
Food & beverage: $468
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $185 |
| Novo Nordisk Inc | 3 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| Lundbeck LLC | 1 | $28 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Exact Sciences Corporation | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| PFIZER INC. | 1 | $21 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $18 |
Products named: AIRSUPRA, FARXIGA, REXULTI, CAPLYTA, Auvelity, Cologuard Collection Kit, NUCALA, ELIQUIS.
Industry payments across MI — which companies pay providers there.
